Skip to search formSkip to main contentSkip to account menu

STA-1474

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Triazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract 3369: The importance of dose schedule with Hsp90 inhibitors: Results from a Phase II study in dogs with mast cell tumors.
Purpose: STA-1474 is the prodrug of ganetespib, currently the most advanced Hsp90 inhibitor in human clinical trials. In a Phase… 
2013
2013
Analysis of HSP90 and HSP70 expression in dogs before and after treatment with STA-1474.
2011
2011
Abstract 1282: Phase I evaluation of STA-1474, a pro-drug of the novel HSP90 inhibitor STA-9090, in dogs with spontaneous cancer
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL The novel water soluble compound STA-1474 is… 
2011
2011
Investigating the Biological and Biochemical Consequences of Met Function and Dysfunction in Canine Osteosarcoma
.............................................................................................................................. ii… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)